Parkinson Disease Clinical Trials in Palo Alto, California

4 studies are recruiting for parkinson disease in Palo Alto, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    This is a Phase 2 study in people with Parkinson's disease who experience motor fluctuations while taking levodopa. The study will evaluate how effective two different doses of the study drug AP-472 are when added to levodopa treatment, compared with a placebo. The study will last about 12 weeks. P…

    Stage
    Phase 2
    Ages
    30 to 80
    Site
    Parkinson's Research Centers of America (Site #218), Palo Alto, California
    Locations
    30 in total
    Run by
    Appello Pharmaceuticals, Inc.

    See if you can join NCT07432958 on ClinicalTrials.gov

  2. A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic p…

    Stage
    Phase 2
    Ages
    40 to 80
    Site
    Parkinson's Research Centers of America - Palo Alto, Palo Alto, California
    Locations
    72 in total
    Run by
    Neuron23 Inc.

    See if you can join NCT06680830 on ClinicalTrials.gov

  3. Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

    Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease

    Stage
    Not phased
    Ages
    18 and older
    Site
    Parkinson's Research Centers of America - Palo Alto, Palo Alto, California
    Locations
    5 in total
    Run by
    Supernus Pharmaceuticals, Inc.

    See if you can join NCT07219927 on ClinicalTrials.gov

  4. A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

    The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

    Stage
    Phase 4
    Ages
    18 and older
    Site
    Parkinson's Research Centers of America - Palo Alto, Palo Alto, California
    Locations
    27 in total
    Run by
    Impax Laboratories, LLC

    See if you can join NCT06765668 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.